Galenica is a well-managed and resilient company that has an unassailable dominance of the Swiss pharma distribution and related services. Over the years the company has earned a quality compounder reputation (+12% annualised TRS since IPO) which is reflected in its 20% average premium vs the SMI. Going forward we expect the company to keep a robust TRS profile of 8-9% p.a. (ex M&A). We initiate our coverage with a Neutral rating as its current premium (30%) and the limited upside to our target...
A director at Galenica AG sold 3,000 shares at 83.305CHF and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Galenica AG / Mot-clé(s) : Personnel Galenica nomme Nadine Balkanyi-Nordmann au Conseil d’administration 23.01.2025 / 07:00 CET/CEST Communiqué de presse Nadine Balkanyi-Nordmann, experte expérimentée en droit, compliance et gouvernance, sera proposée à l’élection au Conseil d’administration lors de la prochaine Assemblée générale du Groupe Galenica. Lors de la prochaine Assemblée générale du 10 avril 2025, il sera proposé aux actionnaires d’élire un nouveau membre au Conseil d’administration de Galenica: Nadine Balkanyi-Nordmann (1972), personnalité dirigeante reconnue et experte...
Galenica AG / Key word(s): Personnel Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors 23.01.2025 / 07:00 CET/CEST Press release Nadine Balkanyi-Nordmann, an experienced legal, compliance and governance expert, will be recommended for election as a member of the Board of Directors at the next Annual General Meeting of the Galenica Group. At the upcoming Annual General Meeting on 10 April 2025, a new member will be proposed to shareholders for election to the Galenica Board of Directors: Nadine Balkanyi-Nordmann (born in 1972), a recognised leader and expert in ...
Galenica AG / Schlagwort(e): Personalie Galenica nominiert Nadine Balkanyi-Nordmann für den Verwaltungsrat 23.01.2025 / 07:00 CET/CEST Medienmitteilung Nadine Balkanyi-Nordmann, erfahrene Expertin in Recht, Compliance und Governance, wird an der nächsten Generalversammlung der Galenica Gruppe zur Wahl als Verwaltungsrätin vorgeschlagen. Anlässlich der kommenden Generalversammlung vom 10. April 2025 wird den Aktionärinnen und Aktionären ein neues Mitglied zur Wahl in den Verwaltungsrat von Galenica vorschlagen: Nadine Balkanyi-Nordmann (1972), anerkannte Führungspersönlichkeit und E...
Galenica AG / Key word(s): Strategic Company Decision Expansion of the Executive Committee and handover of the position of CFO 06.08.2024 / 07:00 CET/CEST Press release Galenica is aligning its pharmacy business to an even greater focus on customers. With Stephan Mignot, Marketing for the pharmacies will have a direct seat on the Executive Committee. In addition, the two strategic growth areas “Products & Brands” and “Home Care” are being merged into a single unit under the management of Thomas Szuran for focused expansion. The changes will enter into force on 1 September 2024. Th...
Galenica AG / Mot-clé(s) : Décision stratégique d’entreprise Élargissement de la Direction et passage de témoin au poste de CFO 06.08.2024 / 07:00 CET/CEST Communiqué de presse Galenica recentre l’activité de ses pharmacies sur une approche plus orientée client; le marketing pour les pharmacies fait son entrée au sein de la Direction en la personne de Stephan Mignot; dans le cadre d’une stratégie de croissance ciblée, les deux secteurs clés «Products & Brands» et «Home Care» vont être fusionnés en une seule unité, placée sous la direction de Thomas Szuran. Autant de nouveautés qui ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.